Avicanna Inc. (TSX:AVCN)
Canada · Delayed Price · Currency is CAD 0.1300
0.00 (0.00%)
Aug 28, 2026, 9:11 AM EST
Avicanna Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 25.31 | 25.48 | 25.46 | 16.79 | 4.05 | 3.27 | |
Revenue Growth | -0.23% | 0.08% | 51.62% | 314.82% | 23.83% | 108.20% |
Cost of Revenue | 11.5 | 11.96 | 13.26 | 10.13 | 2.93 | 0.44 |
Gross Profit | 13.82 | 13.52 | 12.19 | 6.66 | 1.12 | 2.83 |
Selling, General & Admin | 15.17 | 14.2 | 14.32 | 11.89 | 9.22 | 11.87 |
Operating Expenses | 17.37 | 16.3 | 17.84 | 15.04 | 11.53 | 14.25 |
Operating Income | -3.55 | -2.78 | -5.64 | -8.38 | -10.41 | -11.41 |
Interest Expense | -0.06 | -0.05 | -0.33 | -0.61 | -1.67 | -0.74 |
Currency Exchange Gain (Loss) | -0.03 | -0.04 | 0.47 | -0.03 | 0.09 | -0.08 |
Other Non Operating Income (Expenses) | -0.1 | 0.11 | 0.92 | 0.27 | -0.1 | -0.08 |
EBT Excluding Unusual Items | -3.73 | -2.76 | -4.58 | -8.75 | -12.09 | -12.31 |
Gain (Loss) on Sale of Investments | - | - | - | - | - | -0.34 |
Gain (Loss) on Sale of Assets | - | - | -0 | 0 | -1.52 | 0.05 |
Asset Writedown | - | - | - | - | -1.12 | -4.16 |
Pretax Income | -3.73 | -2.76 | -4.58 | -8.74 | -14.74 | -16.76 |
Income Tax Expense | - | - | - | - | - | 0.01 |
Earnings From Continuing Operations | -3.73 | -2.76 | -4.58 | -8.74 | -14.74 | -16.77 |
Net Income | -3.73 | -2.76 | -4.58 | -8.74 | -14.74 | -16.77 |
Net Income to Common | -3.73 | -2.76 | -4.58 | -8.74 | -14.74 | -16.77 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 120 | 115 | 100 | 85 | 59 | 41 |
Shares Outstanding (Diluted) | 120 | 115 | 100 | 85 | 59 | 41 |
Shares Change | 9.70% | 14.69% | 18.09% | 43.17% | 43.31% | 40.45% |
EPS (Basic) | -0.03 | -0.02 | -0.05 | -0.10 | -0.25 | -0.41 |
EPS (Diluted) | -0.03 | -0.02 | -0.05 | -0.10 | -0.25 | -0.41 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -3.19 | -1.44 | -2.95 | -1.45 | -7.49 | -12.43 |
Free Cash Flow Per Share | -0.03 | -0.01 | -0.03 | -0.02 | -0.13 | -0.30 |
Gross Margin | 54.59% | 53.06% | 47.90% | 39.66% | 27.55% | 86.63% |
Operating Margin | -14.02% | -10.92% | -22.16% | -49.90% | -257.18% | -349.15% |
Profit Margin | -14.75% | -10.83% | -17.99% | -52.07% | -364.02% | -513.15% |
Free Cash Flow Margin | -12.61% | -5.64% | -11.59% | -8.63% | -184.94% | -380.32% |
EBITDA | -3.11 | -2.24 | -5.1 | -7.87 | -9.79 | -10.85 |
EBITDA Margin | -12.28% | -8.80% | -20.03% | -46.87% | -241.77% | - |
D&A For EBITDA | 0.44 | 0.54 | 0.54 | 0.51 | 0.62 | 0.56 |
EBIT | -3.55 | -2.78 | -5.64 | -8.38 | -10.41 | -11.41 |
EBIT Margin | -14.02% | -10.92% | -22.16% | -49.90% | -257.18% | - |
Revenue as Reported | 25.31 | 25.48 | 25.46 | 16.79 | 4.05 | 3.27 |